Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001209191-23-049099

Options or other derivatives

  • VP, Pharmaceutical Development acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cappello Joseph · VP, Pharmaceutical Development

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-09-11 Grant or award : show line 1 in the form Stock Option (right to buy) +65,000 $22.40 2033-09-10 65,000 65,000 D
Loading xslF345X05/doc4.xml…